BRIMAZED 2 mg/ml, eye drop solution in a single-dose container 60 single-dose containers of 0.35 ml
Active ingredients: Brimonidine, Brimonidine tartrate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution60 single-dose containers of 0.35 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRIMAZED 2 mg/mL, collyre en solution en récipient unidose
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 60 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,35 ml
- Marketing authorisation holder
- PHARMA STULLN (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 May 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60574868CIP73015008CIP133400930150085Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRIMONIDINEcollyre | 1,3 mg · 1 mL de solution | FT |
| TARTRATE DE BRIMONIDINEcollyre | 2 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.